CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-26 | Wang Xiaodong Director | Grant or award · Share Option (Right to Buy) | +655,044 | 655,044 | ||
| 2018-06-08 | Wang Xiaodong Director | Gift | −5,000,000 | 7,879,311 | ||
| 2018-06-06 | BAKER BROS. ADVISORS LP Director | Grant or award | +18,580 | 6,551,715 | ||
| 2018-06-06 | BAKER BROS. ADVISORS LP Director | Grant or award | +18,580 | 73,180,602 | ||
| 2018-06-06 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +34,884 | 34,884 | ||
| 2018-06-06 | Glazer Donald W. Director | Grant or award | +9,290 | 4,336,932 | ||
| 2018-06-06 | Glazer Donald W. Director | Grant or award · Share Option (Right to Buy) | +17,442 | 17,442 | ||
| 2018-06-06 | Chen Timothy Yung-Cheng Director | Grant or award | +9,290 | 9,290 | ||
| 2018-06-06 | Chen Timothy Yung-Cheng Director | Grant or award · Share Option (Right to Buy) | +17,442 | 17,442 | ||
| 2018-06-06 | Malley Thomas Director | Grant or award | +9,290 | 9,290 | ||
| 2018-06-06 | Malley Thomas Director | Grant or award · Share Option (Right to Buy) | +17,442 | 17,442 | ||
| 2018-06-06 | Yi Qingqing Director | Grant or award | +9,290 | 9,290 | ||
| 2018-06-06 | Yi Qingqing Director | Grant or award · Share Option (Right to Buy) | +17,442 | 17,442 | ||
| 2018-04-30 | OYLER JOHN Chief Executive Officer | Grant or award | +574,938 | 17,265,056 | ||
| 2018-04-30 | OYLER JOHN Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +996,810 | 996,810 | ||
| 2018-04-30 | Wu Xiaobin President & GM China | Grant or award | +1,149,899 | 1,149,899 | ||
| 2018-04-30 | Wu Xiaobin President & GM China | Grant or award · Share Option (Right to Buy) | +766,599 | 766,599 | ||
| 2018-04-02 | su Jingshyh S Director | Grant or award · Share Option (Right to Buy) | +63,290 | 63,290 | ||
| 2018-03-19 | Liang Howard CFO & Chief Strategy Officer | Exercise or conversion | +24,128 | $6.50 | $157K | 29,128 |
| 2018-03-19 | Liang Howard CFO & Chief Strategy Officer | Sale | −500 | $158.45 | $79K | 28,628 |
Page 111 of 123 · 2,455 trades